Photo of { Fenil Patel, MD, MHA}

Fenil Patel, MD, MHA


  • Attending Psychiatrist, Division of Child and Adolescent Psychiatry
  • Assistant Professor, UC Department of Psychiatry and Behavioral Neuroscience
  • Board Certified
My care philosophy begins with listening. I believe the most important part of my work is hearing the unique stories of the children and families I serve.
Fenil Patel, MD, MHA

About

Biography

I am a child and adolescent psychiatrist specializing in the care of young people facing a wide range of mental health challenges. My clinical expertise includes complex psychopharmacology in general outpatient psychiatry, as well as the specialized treatment of neurobehavioral disorders in children with genetic syndromes, intellectual disability and Autism Spectrum Disorder (ASD). I also have a particular interest in neuromodulation therapies, including electroconvulsive therapy (ECT) for children and adolescents with treatment-resistant psychiatric illness.

My care philosophy begins with listening. I believe the most important part of my work is hearing the unique stories of the children and families I serve. No two children navigate their challenges in the exact same way, so I strive to understand the subtle nuances of each presentation. This deep understanding allows me to think critically about a diagnosis and ensure it accurately reflects your child’s reality before we move forward. I view the formulation of a treatment plan as a partnership, where shared decision-making is central. Together, we choose a path that aligns with your goals and values. I also consider how family dynamics, school environments, and community resources shape a child’s progress, and remain mindful of the systemic barriers—such as healthcare policy and affordability—that impact your family’s journey.

Beyond my clinical practice, my research focuses on digital health innovation and the economic forces that shape how we deliver care. I am passionate about exploring how emerging technologies, from telehealth and AI to novel digital therapeutics, can expand access and reduce costs for families navigating complex psychiatric and neurodevelopmental conditions. My goal is to help bridge the gap between clinical knowledge, technological advancements, affordability, and real-world accessibility, ensuring that the next generation of psychiatric care is both effective and economically viable for all families in our community.

BS: Biology, York University, Toronto, Canada, 2012

MD: The Ohio State University, College of Medicine, 2019

Residency: Psychiatry, Cleveland Clinic Foundation, 2022

Fellowship: Child & Adolescent Psychiatry, Cincinnati Children’s Hospital Medical Center, 2024

MHA: Cornell University, Brooks School of Public Policy, 2025

Interests

Pediatric neurobehavioral disorders including autism spectrum disorder (ASD), intellectual disability, and rare genetic syndromes; complex pediatric psychopharmacology; neuromodulation therapies, specializing in the use of electroconvulsive therapy (ECT) for treatment-resistant psychiatric conditions; outpatient child and adolescent psychiatry

Services and Specialties

Interests

Digital health innovation, exploring how telehealth and AI-driven tools can be integrated into routine clinical practice; technology-enhanced care delivery, investigating the clinical efficacy and implementation of virtual reality, wearables, and digital therapeutics; health economics and finance, analyzing how payment models and reimbursement structures impact the affordability of mental health care; health services research, bridging the gap between clinical advancements and real-world accessibility for families; scalability in healthcare, developing strategies to move innovation from the bedside to the broader market; policy and advocacy, addressing the systemic barriers and regulatory frameworks that impact economic feasibility, accessibility and affordability.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Novel therapeutics in autism spectrum disorder. Elmaghraby, R; Patel, F; Brown, H; Gorenstein, M; Bain, J; Grinspan, ZM; Pedapati, E; Veenstra-Vanderweele, J; Vandana, P. Neurotherapeutics. 2026; e00857.

Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Hann, H-W; Wan, S; Lai, Y; Hann, RS; Myers, RE; Patel, F; Zhang, K; Ye, Z; Wang, C; Yang, H. Journal of Gastroenterology and Hepatology (Australia). 2015; 30(1):131-138.

Genetic variations in colorectal cancer risk and clinical outcome. Zhang, K; Civan, J; Mukherjee, S; Patel, F; Yang, H. World Journal of Gastroenterology. 2014; 20(15):4167-4177.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...